INSUBCONTINENT EXCLUSIVE:
Dr Reddy's has entered into a contract with Citius Pharma to sell its rights to anti-cancer agentThe domestic stock exchange are likely to
open in the green, continuing with the strength in the previous trading session
The Nasdaq closed Friday at a fresh record, however Wall Street's primary indexes headed into the Labor Day weekend in blended fashion
reacting to a frustrating U.S
Asian shares got off to a blended start on Monday as a frustrating U.S
payrolls report guaranteed to keep policy there super-loose for longer
Trends on SGX Nifty show a positive opening for the Nifty, with a 46-points gain.The Sensex had actually climbed 277.41 indicate 58,129.95
and the Nifty had leapt 89.40 points to 17,323.60
Stocks to see in trade in today's sessionAshoka BuildconAshoka Buildcon has actually received the letter of award from Adani Roadway
Transportation for the execution of civil and involved deal with engineering, procurement - & building (EPC) for six- laning of the national
corridor NH-19 from Pangarh to Palsit in West Bengal.Dr Reddy's LaboratoriesDr Reddy's Laboratories has participated in a conclusive
arrangement with Citius Pharmaceuticals to offer its rights to anti-cancer agent E7777 (denileukin diftitox)
ICICI LombardICICI Lombard has actually gotten regulatory and other approvals from the Insurance Regulatory and Development Authority of
India (IRDAI) for the demerger of the general insurance coverage company of Bharti AXA General.
